Product Detail  

  Product Detail  

What is SS-31?
Elamipretide (SS-31) is a small peptide that can reach inside the mitochondria and affect mitochondrial function maintenance. Elamipretide belongs to a family of cell-penetrating peptides that target and accumulate at the inner mitochondrial membrane. Inside the mitochondria, elamipretide binds to cardiolipin, an essential component of the inner mitochondrial membrane, and restores the mitochondria.

Given the effects of elamipretide on mitochondrial function and maintenance, treatment with elamipretide is under investigation to determine its benefits on human health. Recently, scientists have discovered at least four excellent benefits that can potentially make elamipretide a viable treatment option for a wide variety of conditions.

In diabetes research, SS-31 can improve mitochondrial dysfunction related to diabetes and has potential value in the treatment of diabetes and its complications. For sepsis, SS-31 can reduce vascular permeability in septic rats. The protective effect is related to the inhibition of oxidative stress, providing a new strategy for clinical treatment.

SS-31 Benefits:

• Elamipretide Can Treat Mitochondrial Dysfunction
• Elamipretide Can Prevent Cardiovascular Disease Risk
• Reduces internal inflammation
• Elamipretide Can Improve Cognitive Impairment
• Elamipretide Can Enhance Physical Endurance

Retatrutide —developed by pharmaceutical giant Eli Lilly and alternatively known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943—is an injectable breakthrough poised for FDA approval, with significant potential to treat obesity and diabetes. While it shares similarities with established weight loss therapies like tirzepatide and semaglutide, retatrutide delivers enhanced efficacy. When paired with balanced nutrition, consistent physical activity, and healthy lifestyle adjustments, it not only amplifies weight loss results but also addresses obesity-related comorbidities such as diabetes and hypertension (high blood pressure).

What sets retatrutide apart from other weight loss medications is its superior effectiveness, driven by three key therapeutic mechanisms:

**Gastric Inhibitory Polypeptide Receptor (GIPR) Agonism: By activating GIP receptors, retatrutide strengthens appetite control, blocks fat storage, reduces caloric intake, and boosts energy expenditure.
**Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonism: It supports weight reduction by improving glycemic control—stimulating pancreatic insulin secretion while curbing the release of glucagon, a hormone that elevates blood sugar levels.
**Glucagon Receptor (GR) Agonism**: Retatrutide further regulates blood glucose by suppressing glucagon release, diminishes food cravings, and increases energy burn, all of which contribute to meaningful weight loss.

Products Name : Retatrutide
Trade Name : LY-3437943
CAS No. :2381089-83-2
Molecular Formula : C221H342N46O68
Molecular Weight : 4731.33g/mol
Sequence:Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{ α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Appearance : White Lyophilized powder
Reconstitution:  Required 
Storage : After reconstitution store at 2°C - 8°C

BENEFITS OF GLP-1 AGONISTS

• Slows gastric emptying to prolong feelings of fullness
• Suppresses excessive hepatic glucose production (prevents the liver from overproducing sugar)
• Stimulates pancreatic insulin secretion in response to elevated blood glucose levels
• Aids in glycemic control and blood sugar regulation
• Alleviates hyperglycemia, particularly postprandial (after-meal) spikes
• Reduces fasting insulin concentrations and fasting blood glucose levels
• Lowers hemoglobin A1c (HbA1c) to improve long-term glycemic outcomes
• Curbs appetite and reduces caloric consumption, while counteracting weight gain
• Demonstrates efficacy in lowering triglyceride levels and mitigating oxidative stress associated with high LDL ("bad" cholesterol)
• Promotes weight loss in obese patients when administered at higher dosages
• Decreases leptin levels and enhances leptin sensitivity (improving the body’s ability to regulate hunger and metabolism)

Facilitates the browning of white adipose tissue (converts energy-storing white fat to energy-burning brown fat)

  Product Detail  

  Product Detail